Concepedia
Statistics
Publications
19
Citations
1.1K
H-Index
18
Active since
1989
Affiliations
Bristol-Myers Squibb (Switzerland)(Current)
University of Georgia
New York City College of Technology
Argus International (United States)
Rutgers, The State University of New Jersey
Vikram Khetani is an author at Bristol-Myers Squibb (Switzerland) specializing in pharmacology, medicine, and chemistry.
Publications per year
1989–2020
A 90-day oral gavage toxicity study of d-methylphenidate and d,l-methylphenidate in Sprague–Dawley rats
Steve Teo, David Stirling, Steve D. Thomas et al. · Toxicology · 2002 · 347 citations
Pharmacy, Pharmacology, Toxicology +10
Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study
Mark N. Polizzotto, Thomas S. Uldrick, Kathleen M. Wyvill et al. · Journal of Clinical Oncology · 2016 · 139 citations · Full text
Medicine, Oncology, Pharmacology +14
Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model
Selvakumar Subbian, Liana Tsenova, Jennifer Holloway et al. · EBioMedicine · 2016 · 81 citations · Full text
Medicine, Infectious Diseases, Pharmacology +10
A Concise Two-Step Synthesis of Thalidomide
George W. Muller, William E. Konnecke, Alison M. Smith et al. · Organic Process Research & Development · 1999 · 65 citations
Natural Sciences, Chemistry, Medicinal Chemistry +4
Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis
Selvakumar Subbian, Mi-Sun Koo, Liana Tsenova et al. · Frontiers in Immunology · 2016 · 49 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +16
1–5 of 19